Our study demonstrated that SLP-2 overexpression was associated with disease progression and poor survival outcomes for patients with epithelial ovarian cancer, and thus SLP-2 may be regarded as a potential prognostic factor. This evidence concerns the gene STOML2 and ovarian carcinoma.